NO20070785L - Sammensetninger for levering av svaert vannloselige medikamenter. - Google Patents

Sammensetninger for levering av svaert vannloselige medikamenter.

Info

Publication number
NO20070785L
NO20070785L NO20070785A NO20070785A NO20070785L NO 20070785 L NO20070785 L NO 20070785L NO 20070785 A NO20070785 A NO 20070785A NO 20070785 A NO20070785 A NO 20070785A NO 20070785 L NO20070785 L NO 20070785L
Authority
NO
Norway
Prior art keywords
compositions
delivery
soluble drugs
heavily water
heavily
Prior art date
Application number
NO20070785A
Other languages
English (en)
Inventor
Andrew Xian Chen
Original Assignee
Sd Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sd Pharmaceuticals Inc filed Critical Sd Pharmaceuticals Inc
Publication of NO20070785L publication Critical patent/NO20070785L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Foreliggende oppfinnelse tilveiebringer blandinger for levering av svært vannløselige medikamenter (slik som vinkaalkaloider) og fremgangsmåter for anvendelse av slike blandinger.
NO20070785A 2004-07-12 2007-02-09 Sammensetninger for levering av svaert vannloselige medikamenter. NO20070785L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/889,226 US7871632B2 (en) 2004-07-12 2004-07-12 Compositions for delivering highly water soluble drugs
PCT/US2005/024594 WO2006017246A2 (en) 2004-07-12 2005-07-12 Compositions for delivering highly water soluble drugs

Publications (1)

Publication Number Publication Date
NO20070785L true NO20070785L (no) 2007-04-02

Family

ID=35541622

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070785A NO20070785L (no) 2004-07-12 2007-02-09 Sammensetninger for levering av svaert vannloselige medikamenter.

Country Status (18)

Country Link
US (4) US7871632B2 (no)
EP (1) EP1773294A4 (no)
JP (1) JP4643641B2 (no)
KR (1) KR20070032816A (no)
CN (1) CN1859898B (no)
AU (1) AU2005271873A1 (no)
BR (1) BRPI0513178A (no)
CA (1) CA2578574C (no)
EA (1) EA012522B1 (no)
EC (1) ECSP077238A (no)
IL (1) IL180350A0 (no)
MA (1) MA29662B1 (no)
MX (1) MX2007000416A (no)
NO (1) NO20070785L (no)
RS (1) RS20070029A (no)
TW (1) TW200607525A (no)
WO (1) WO2006017246A2 (no)
ZA (1) ZA200701167B (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005269383A1 (en) * 2004-07-28 2006-02-09 Sd Pharmaceuticals, Inc. Stable injectable composition of alpha tocopheryl succinate, analogues and salts thereof
US8557861B2 (en) * 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
CN101011355B (zh) * 2006-02-01 2013-01-02 陈献 经维生素e琥珀酸酯稳定的医药组合物、其制备及用途
TWI376239B (en) * 2006-02-01 2012-11-11 Andrew Xian Chen Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
EP2023895A2 (en) * 2006-05-12 2009-02-18 Adventrx Pharmaceuticals, Inc. Pharmaceutical compositions for vein irritating drugs
WO2009078756A1 (en) * 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
WO2009078754A1 (en) 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of poorly water soluble pharmaceutically active substances
US8618056B2 (en) * 2007-12-22 2013-12-31 Cuthbert O. Simpkins Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
US8063020B2 (en) * 2007-12-22 2011-11-22 Simpkins Cuthbert O Resuscitation fluid
US8906855B2 (en) * 2007-12-22 2014-12-09 Vivacelle Bio, Inc. Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
WO2009108689A1 (en) * 2008-02-25 2009-09-03 Novavax, Inc. Sugar glassified virus like particles (vlps)
US20090286832A1 (en) * 2008-05-15 2009-11-19 Kiichiro Nabeta Narcotic emulsion formulations for treatment of surgical pain
KR20110099747A (ko) 2009-02-26 2011-09-08 테이코쿠 팔마 유에스에이, 인코포레이티드 암 통증 치료용 마취 유상액 제제
CN101879138A (zh) 2009-05-06 2010-11-10 上海恒瑞医药有限公司 长春花生物碱纳米乳剂注射液及其制备方法
BR112012003263A2 (pt) 2009-08-14 2015-09-22 Opko Health Inc formulações intravenosas de antagonistas de neuroquinina-1
ES2640756T3 (es) * 2010-10-22 2017-11-06 Dr. Reddy's Laboratories Sa. Uso de depósitos de fosfolipidos viscosos estables para tratar heridas
WO2012135856A2 (en) * 2011-04-01 2012-10-04 Spectrum Pharmaceuticals, Inc. Very low dose vinorelbine for treatment of cancer
CN102743337B (zh) * 2011-04-20 2014-04-16 国家纳米科学中心 一种纳米粒子药物组合物及其制备方法
US20140249077A1 (en) * 2011-06-09 2014-09-04 Astrazeneca Pharmaceuticals Lp Gel compositions
US20140328759A1 (en) 2011-10-25 2014-11-06 The University Of British Columbia Limit size lipid nanoparticles and related methods
CN104427976B (zh) 2012-05-10 2018-04-24 佩因拉佛姆有限公司 疏水的活性成分的储库制剂及其制备方法
US20140275261A1 (en) 2013-03-15 2014-09-18 Dr. Reddy's Laboratories, Inc. Diclofenac parenteral compositions
WO2014172045A1 (en) 2013-03-15 2014-10-23 The University Of British Columbia Lipid nanoparticles for transfection and related methods
US20160290093A1 (en) * 2015-04-02 2016-10-06 Baker Hughes Incorporated Disintegrating Compression Set Plug with Short Mandrel
JP6951825B2 (ja) 2015-09-04 2021-10-20 ザ スクリプス リサーチ インスティテュート インスリン免疫グロブリン融合タンパク質
CN116546973A (zh) * 2020-11-19 2023-08-04 日本化药株式会社 含有发生血管障碍的水溶性药物的组合物、含有发生血管障碍的水溶性药物的给药液调制用溶液、试剂盒、血管障碍抑制剂和含有非离子型表面活性剂的溶液
US12419850B1 (en) 2024-03-21 2025-09-23 GanD, Inc. Bioactive fluid compositions

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US224042A (en) * 1880-02-03 Music-rest for piano-fortes
US670001A (en) * 1900-02-15 1901-03-19 Stephen B Morss Combined curb and gutter.
US4816247A (en) * 1985-09-11 1989-03-28 American Cyanamid Company Emulsion compositions for administration of sparingly water soluble ionizable hydrophobic drugs
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers
KR920700655A (ko) 1989-05-26 1992-08-10 찰스 엠. 브럭 주사가능한 클라리트로마이신 조성물
US5399363A (en) * 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
CA2231682A1 (en) * 1995-09-13 1997-03-20 Junzo Seki Pge1-containing freeze-dried preparation and the production thereof
WO1998000110A1 (en) * 1996-07-03 1998-01-08 University Of Pittsburgh Emulsion formulations for hydrophilic active agents
US6432994B1 (en) * 1997-04-28 2002-08-13 Texas Biotechnology Corporation Sulfonamides for treatment of endothelin-mediated disorders
US6723338B1 (en) * 1999-04-01 2004-04-20 Inex Pharmaceuticals Corporation Compositions and methods for treating lymphoma
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US6720001B2 (en) * 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
GB9925127D0 (en) 1999-10-22 1999-12-22 Pharmacia & Upjohn Spa Oral formulations for anti-tumor compounds
US6136846A (en) * 1999-10-25 2000-10-24 Supergen, Inc. Formulation for paclitaxel
JP2003277281A (ja) * 2002-03-20 2003-10-02 Kumamoto Technology & Industry Foundation 静脈炎の予防及び治療のための医薬
US6890558B2 (en) 2002-05-31 2005-05-10 R.P. Scherer Technologies, Inc. Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
JP4426749B2 (ja) * 2002-07-11 2010-03-03 株式会社産学連携機構九州 Ｏ／ｗ型エマルション製剤
US20050049209A1 (en) * 2003-08-06 2005-03-03 Chen Andrew Xian Pharmaceutical compositions for delivering macrolides
AU2005269383A1 (en) * 2004-07-28 2006-02-09 Sd Pharmaceuticals, Inc. Stable injectable composition of alpha tocopheryl succinate, analogues and salts thereof
CN1634058A (zh) * 2004-10-20 2005-07-06 李晓祥 长春瑞滨乳剂及其制备方法

Also Published As

Publication number Publication date
US20060008480A1 (en) 2006-01-12
WO2006017246A2 (en) 2006-02-16
WO2006017246A3 (en) 2006-03-30
BRPI0513178A (pt) 2008-04-29
MX2007000416A (es) 2007-03-28
RS20070029A (sr) 2008-11-28
EP1773294A4 (en) 2012-11-21
CA2578574C (en) 2013-09-10
CN1859898A (zh) 2006-11-08
JP4643641B2 (ja) 2011-03-02
CN1859898B (zh) 2011-06-08
EA200700312A1 (ru) 2007-08-31
HK1100062A1 (en) 2007-09-07
KR20070032816A (ko) 2007-03-22
AU2005271873A1 (en) 2006-02-16
US20120046310A1 (en) 2012-02-23
US7871632B2 (en) 2011-01-18
US20130029918A1 (en) 2013-01-31
TW200607525A (en) 2006-03-01
MA29662B1 (fr) 2008-08-01
EA012522B1 (ru) 2009-10-30
EP1773294A2 (en) 2007-04-18
US20110082168A1 (en) 2011-04-07
ECSP077238A (es) 2007-04-26
US8026250B2 (en) 2011-09-27
US8222268B2 (en) 2012-07-17
JP2008505972A (ja) 2008-02-28
CA2578574A1 (en) 2006-02-16
IL180350A0 (en) 2007-06-03
ZA200701167B (en) 2010-08-25

Similar Documents

Publication Publication Date Title
UA86591C2 (ru) Пирролодигидроизохинолины как ингибиторы pde10, фармацевтическая композиция на их основе
MY154898A (en) P70 s6 kinase inhibitors
NO20071078L (no) Antivirale forbindelser
NO20070866L (no) Antivirale forbindelser.
NO20090596L (no) Antivirale fosfinatforbindelser
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
TW200744665A (en) Vitamin E succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
SE0301700D0 (sv) Novel compounds
CY1109010T1 (el) γ-ΚΡΥΣΤΑΛΛΙΚΗ ΜΟΡΦΗ ΤΗΣ ΥΔΡΟΧΛΩΡΙΚΗΣ ΙΒΑΒΡΑΔΙΝΗΣ, ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΤΗΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΤΗΝ ΠΕΡΙΕΧΟΥΝ
ATE430747T1 (de) 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren
NO20170633A1 (no) Forbindelser av indolamin-2,3-dioksygenase for anvendelse i behandling av kreft i kombinasjon med et anti-PD-1 antistoff .
CY1117639T1 (el) Φαρμακευτικες συνθεσεις βασιζομενες επι κρυσταλλικης μορφης i της 5-αζακυτιδινης
DK1934174T3 (da) Azetidiner som MEK inhibitorer til behandling af proliferative sygdomme
WO2006007448A3 (en) Pharmaceutical co-crystal compositions and related methods of use
ATE362932T1 (de) Azaindolverbindungen als kinaseinhibitoren
ATE534383T1 (de) Zusammensetzungen aus n-ä2,4-bis(1,1- dimethylethyl)-5-hydroxyphenylü-1,4-dihydro-4- oxochinolin-3-carboxamid
MX2010006738A (es) Inhibidores de proteasa del virus de la hepatitis c (hcv) y usos de los mismos.
EA201170227A1 (ru) Имидазолкарбоксамиды
TW200607525A (en) Compositions for delivering highly water soluble drugs
TN2011000207A1 (en) Akt and p70 s6 kinase inhibitors
CA2672094C (en) Methods and apparatus for identifying subject matter in view data
NO20065726L (no) Forbindelser og sammensetninger for avlevering av aktive forbindelser.
MEP34308A (en) Oral formulations of cladribine
MXPA05013758A (es) Composiciones farmaceuticas que incluyen una antihistamina y un estimulante y uso de las mismas.
NO20062878L (no) Isoflavonoidpromedikamenter, terapeutiske sammensetninger derav og terapeutiske fremgangsmater som innbefatter de samme

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application